- (Labs)
- (NIH - NIAID)
NIH - NIAID
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
About the lab
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. Among the 27 Institutes and Centers that comprise the National Institutes of Health, NIAID has a unique mandate, which requires the Institute to respond to emerging public health threats. Toward this end, NIAID manages a complex and diverse research portfolio that aims to do the following:
- Expand the breadth and depth of knowledge in all areas of infectious, immunologic, and allergic diseases.
- Develop flexible domestic and international research capacities to respond appropriately to emerging and re-emerging disease threats at home and abroad.
Members
Daniel Douek
M.D.Ph.D
Scientific CommittéeExperience
- Senior Investigator and the Chief of the Human Immunilogy Section, Vaccine Research Center, NIAID, National Insitutes of Health, Bethesda, USA.
- Phd - Immunology at the University of London.
- Appointed to the NIH Vaccine Research Center in November 2000 and NIH Director’s Award in 2008.
- Received the World AIDS Day Award in 2007.
- One of the world’s top 50 scientists by Scientific American in 2005.
- Named as one of the 2012 POZ 100 for his significant contributions to accelerating the end of AIDS.
Projects
Several locations will remain susceptible to yearly DENV and ZIKV outbreaks, while new regions across the globe will likely suffer epidemics similar to the one described in South.
